Abstract:Pancreatic cancer is known to have a high mortality rate, and its early diagnosis remains challenging due to the occult location of the pancreas. Exosomes derived from pancreatic cancer cells specifically express glypican-1, which may provide a liquid biopsy opportunity for the early diagnosis of pancreatic cancer. Herein, an inductively coupled plasma mass spectrometry (ICP-MS) and photothermal dual-readout platform was proposed for the ultrasensitive and point-of-care analysis of pancreatic cancer exosomes. In our design, exosomes were specifically captured by the sandwich immunoassay, and simultaneously, alkaline phosphatase was introduced in a low-background manner. The alkaline phosphatase triggered the hydrolysis of l-ascorbic acid 2-phosphate to produce ascorbic acid, followed by the etching of Fe3O4@MnO2 nanoflowers. As a result, the Mn2+ generated by etching stripped off the Fe3O4 and was quantified using ICP-MS. Meanwhile, the reduced Fe3O4@MnO2 was applied for the photothermal assay by oxidizing dopamine with MnO2. The protocol exhibits a detection limit down to 19.1 particles mL–1, which is the most sensitive protocol reported so far. To our knowledge, this is the first endeavor for exosome quantification using ICP-MS and photothermal methods. The developed dual-readout platform not only is capable of distinguishing pancreatic cancer patients from healthy people, but also shows excellent discernibility of individual differences at low concentrations of exosomes. This dual-readout assay is a promising platform for the ultrasensitive and point-of-care detection of exosomes in liquid biopsy-based early cancer diagnosis.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.analchem.1c02004.Chemicals and materials; Cell culture and exosome isolation; Schematic illustration of preparing Fe3O4@MnO2 nanoflowers; Schematic illustration of ALP-induced etching of Fe3O4@MnO2 nanoflowers; Characterization of exosomes isolated by the ultracentrifugation and magnetic separation; UV–vis absorption spectra of polydopamine nanoparticles and dopamine; Optimization of experimental parameters; Table of operating parameters for ICP-MS detection of exosomes; and Table of comparison of the developed method with the reported methods for exosome quantification (PDF)This article has not yet been cited by other publications.

Early Diagnosis and Prognosis Prediction of Pancreatic Cancer Using Engineered Hybrid Core-Shells in Laser Desorption/Ionization Mass Spectrometry

Multiplexed nanomaterial-assisted laser desorption/ionization for pan-cancer diagnosis and classification

Accurate Cancer Diagnosis and Stage Monitoring Enabled by Comprehensive Profiling of Different Types of Exosomal Biomarkers: Surface Proteins and Mirnas

Combined SERS Microfluidic Chip with Gold Nanocone Array for Effective Early Lung Cancer Prognosis in Mice Model

Highly sensitive microfluidic sensor using integrated optical fiber and real-time single-cell Raman spectroscopy for diagnosis of pancreatic cancer

Diagnosis of pancreatic adenocarcinoma using protein chip technology.

Nanomaterials Augmented LDI-TOF-MS for Pancreatic Ductal Adenocarcinoma Diagnosis and Classification.

Biofluids Metabolic Profiling Based on PS@Fe 3 O 4 –NH 2 Magnetic Beads-Assisted LDI-MS for Liver Cancer Screening

Evaluation of the Effectiveness of a Chemoprevention Model of Pancreatic Adenocarcinoma Using Protein Chip Technology.

Serum Metabolic Fingerprints on Bowl-Shaped Submicroreactor Chip for Chemotherapy Monitoring

Serum Lipidomic Fingerprints Encode Early Diagnosis and Staging of Lung Cancer on a Novel PbS/Au-Layered Substrate

Defective Fe Metal–Organic Frameworks Enhance Metabolic Profiling for High‐Accuracy Diagnosis of Human Cancers

Accelerated Exosomal Metabolic Profiling Enabled by Robust On‐Target Array Sintering with Metal–Organic Frameworks

Single cell glycan-linkages profiling for hepatocellular carcinoma early diagnosis using lanthanide encoded bacteriophage MS2 based ICP-MS

Diagnosis and Prognosis of Breast Cancer by High-Performance Serum Metabolic Fingerprints

Hollow multishelled heterostructures with enhanced performance for laser desorption/ionization mass spectrometry based metabolic diagnosis

ICP-MS and Photothermal Dual-Readout Assay for Ultrasensitive and Point-of-Care Detection of Pancreatic Cancer Exosomes

Homogeneous Multiplex Immunoassay for One-Step Pancreatic Cancer Biomarker Evaluation

Label-Free Histology and Evaluation of Human Pancreatic Cancer with Coherent Nonlinear Optical Microscopy.

Single hollow-core microstructure fiber biosensor for pancreatic cancer diagnosis in terahertz regime

Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment.